FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study

Authorized Users Only
2017
Authors
Radojcić, Maja R.
El Marroun, Hanan
Miljković, Branislava
Stricker, Bruno H. C.
Jaddoe, Vincent W. V.
Verhulst, Frank C.
White, Tonya
Tiemeier, Henning
Article (Published version)
Metadata
Show full item record
Abstract
Benzodiazepines and benzodiazepine-related medications (BBRMs) are anxiolytics and hypnotics acting on amino butyric acid (GABA)A receptors. BBRMs are assumed to have a low potential for major congenital malformations, but research on more subtle and protracted developing symptoms of these medications is lacking. Therefore, we prospectively investigated the association between BBRM use in pregnancy and long-term effects on child behavior in a large population-based cohort study. The study population consisted of 104 children prenatally exposed to BBRM, 527 children exposed to maternal prenatal anxiety or phobic anxiety symptoms (without exposure to BBRM), and 5609 control children. At child age, 6 years, Oppositional Defiant Disorder (ODD), Aggressive Behavior and Anxiety Problems were assessed by the Child Behavior Checklist (CBCL) reported by the mother and the Teacher Report Form (TRF). Children prenatally exposed to BBRM had higher scores of ODD and aggressive behavior, but not of ...anxiety. However, these associations were explained by maternal anxiety symptoms during pregnancy. Moreover, prenatal exposure to anxiety (without exposure to BBRM) was associated with increased scores of child ODD, aggressive behavior, and anxiety. In conclusion, the current study demonstrates that prenatal BBRM exposure was not independently associated with ODD and aggressive behavior in childhood when prenatal anxiety symptoms were taken into account.

Source:
Neurotoxicology and Teratology, 2017, 61, 58-65
Publisher:
  • Pergamon-Elsevier Science Ltd, Oxford
Funding / projects:
  • Erasmus Mundus-Western Balkans grant (ERAWEB) - 2011-2586/001-001-EMA2
  • Erasmus Medical Center

DOI: 10.1016/j.ntt.2017.02.005

ISSN: 0892-0362

PubMed: 28259732

WoS: 000403512700007

Scopus: 2-s2.0-85014624193
[ Google Scholar ]
18
11
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/2982
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Radojcić, Maja R.
AU  - El Marroun, Hanan
AU  - Miljković, Branislava
AU  - Stricker, Bruno H. C.
AU  - Jaddoe, Vincent W. V.
AU  - Verhulst, Frank C.
AU  - White, Tonya
AU  - Tiemeier, Henning
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2982
AB  - Benzodiazepines and benzodiazepine-related medications (BBRMs) are anxiolytics and hypnotics acting on amino butyric acid (GABA)A receptors. BBRMs are assumed to have a low potential for major congenital malformations, but research on more subtle and protracted developing symptoms of these medications is lacking. Therefore, we prospectively investigated the association between BBRM use in pregnancy and long-term effects on child behavior in a large population-based cohort study. The study population consisted of 104 children prenatally exposed to BBRM, 527 children exposed to maternal prenatal anxiety or phobic anxiety symptoms (without exposure to BBRM), and 5609 control children. At child age, 6 years, Oppositional Defiant Disorder (ODD), Aggressive Behavior and Anxiety Problems were assessed by the Child Behavior Checklist (CBCL) reported by the mother and the Teacher Report Form (TRF). Children prenatally exposed to BBRM had higher scores of ODD and aggressive behavior, but not of anxiety. However, these associations were explained by maternal anxiety symptoms during pregnancy. Moreover, prenatal exposure to anxiety (without exposure to BBRM) was associated with increased scores of child ODD, aggressive behavior, and anxiety. In conclusion, the current study demonstrates that prenatal BBRM exposure was not independently associated with ODD and aggressive behavior in childhood when prenatal anxiety symptoms were taken into account.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Neurotoxicology and Teratology
T1  - Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study
VL  - 61
SP  - 58
EP  - 65
DO  - 10.1016/j.ntt.2017.02.005
ER  - 
@article{
author = "Radojcić, Maja R. and El Marroun, Hanan and Miljković, Branislava and Stricker, Bruno H. C. and Jaddoe, Vincent W. V. and Verhulst, Frank C. and White, Tonya and Tiemeier, Henning",
year = "2017",
abstract = "Benzodiazepines and benzodiazepine-related medications (BBRMs) are anxiolytics and hypnotics acting on amino butyric acid (GABA)A receptors. BBRMs are assumed to have a low potential for major congenital malformations, but research on more subtle and protracted developing symptoms of these medications is lacking. Therefore, we prospectively investigated the association between BBRM use in pregnancy and long-term effects on child behavior in a large population-based cohort study. The study population consisted of 104 children prenatally exposed to BBRM, 527 children exposed to maternal prenatal anxiety or phobic anxiety symptoms (without exposure to BBRM), and 5609 control children. At child age, 6 years, Oppositional Defiant Disorder (ODD), Aggressive Behavior and Anxiety Problems were assessed by the Child Behavior Checklist (CBCL) reported by the mother and the Teacher Report Form (TRF). Children prenatally exposed to BBRM had higher scores of ODD and aggressive behavior, but not of anxiety. However, these associations were explained by maternal anxiety symptoms during pregnancy. Moreover, prenatal exposure to anxiety (without exposure to BBRM) was associated with increased scores of child ODD, aggressive behavior, and anxiety. In conclusion, the current study demonstrates that prenatal BBRM exposure was not independently associated with ODD and aggressive behavior in childhood when prenatal anxiety symptoms were taken into account.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Neurotoxicology and Teratology",
title = "Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study",
volume = "61",
pages = "58-65",
doi = "10.1016/j.ntt.2017.02.005"
}
Radojcić, M. R., El Marroun, H., Miljković, B., Stricker, B. H. C., Jaddoe, V. W. V., Verhulst, F. C., White, T.,& Tiemeier, H.. (2017). Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study. in Neurotoxicology and Teratology
Pergamon-Elsevier Science Ltd, Oxford., 61, 58-65.
https://doi.org/10.1016/j.ntt.2017.02.005
Radojcić MR, El Marroun H, Miljković B, Stricker BHC, Jaddoe VWV, Verhulst FC, White T, Tiemeier H. Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study. in Neurotoxicology and Teratology. 2017;61:58-65.
doi:10.1016/j.ntt.2017.02.005 .
Radojcić, Maja R., El Marroun, Hanan, Miljković, Branislava, Stricker, Bruno H. C., Jaddoe, Vincent W. V., Verhulst, Frank C., White, Tonya, Tiemeier, Henning, "Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study" in Neurotoxicology and Teratology, 61 (2017):58-65,
https://doi.org/10.1016/j.ntt.2017.02.005 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB